[HTML][HTML] Combination of ipilimumab and nivolumab in cancers: from clinical practice to ongoing clinical trials
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
[PDF][PDF] Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani, N Hosseinkhani… - Int. J. Mol …, 2020 - researchgate.net
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani, N Hosseinkhani… - INTERNATIONAL …, 2020 - iris.unitn.it
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials.
O Kooshkaki, A Derakhshani… - … Journal of Molecular …, 2020 - europepmc.org
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani… - International …, 2020 - search.proquest.com
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials.
O Kooshkaki, A Derakhshani… - International …, 2020 - search.ebscohost.com
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
[HTML][HTML] Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani… - … Journal of Molecular …, 2020 - ncbi.nlm.nih.gov
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
[PDF][PDF] Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani, N Hosseinkhani… - Int. J. Mol. Sci, 2020 - iris.unime.it
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
O Kooshkaki, A Derakhshani, N Hosseinkhani… - 2020 - agris.fao.org
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …